Beyond the well-known effects on blood pressure (BP) of the dietary approaches to stop hypertension (DASH) and the Mediterranean diets, a large number of studies has investigated the possible BP lowering effect of different dietary supplements and nutraceuticals, the most part of them being antioxidant agents with a high tolerability and safety profile. In particular relatively large body of evidence support the use of potassium, l-arginine, vitamin C, cocoa flavonoids, beetroot juice, coenzyme Q10, controlled-release melatonin, and aged garlic extract. However there is a need for data about the long-term safety of a large part of the above discussed products. Moreover further clinical research is advisable to identify between the available active nutraceuticals those with the best cost-effectiveness and risk–benefit ratio for a large use in general population with low-added cardiovascular risk related to uncomplicated hypertension.

Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses / Cicero, Arrigo F. G.; Colletti, Alessandro. - In: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. - ISSN 1120-9879. - STAMPA. - 22:3(2015), pp. 203-213. [10.1007/s40292-015-0081-8]

Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses

CICERO, ARRIGO FRANCESCO GIUSEPPE;
2015

Abstract

Beyond the well-known effects on blood pressure (BP) of the dietary approaches to stop hypertension (DASH) and the Mediterranean diets, a large number of studies has investigated the possible BP lowering effect of different dietary supplements and nutraceuticals, the most part of them being antioxidant agents with a high tolerability and safety profile. In particular relatively large body of evidence support the use of potassium, l-arginine, vitamin C, cocoa flavonoids, beetroot juice, coenzyme Q10, controlled-release melatonin, and aged garlic extract. However there is a need for data about the long-term safety of a large part of the above discussed products. Moreover further clinical research is advisable to identify between the available active nutraceuticals those with the best cost-effectiveness and risk–benefit ratio for a large use in general population with low-added cardiovascular risk related to uncomplicated hypertension.
2015
Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses / Cicero, Arrigo F. G.; Colletti, Alessandro. - In: HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION. - ISSN 1120-9879. - STAMPA. - 22:3(2015), pp. 203-213. [10.1007/s40292-015-0081-8]
Cicero, Arrigo F. G.; Colletti, Alessandro
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/545125
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 25
social impact